Mahboobeh Safaeian

Mahboobeh Safaeian

UNVERIFIED PROFILE

Are you Mahboobeh Safaeian?   Register this Author

Register author
Mahboobeh Safaeian

Mahboobeh Safaeian

Publications by authors named "Mahboobeh Safaeian"

Are you Mahboobeh Safaeian?   Register this Author

73Publications

1676Reads

6Profile Views

Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial.

J Natl Cancer Inst 2018 02;110(2)

Roche Molecular Diagnostics, Pleasanton, CA; National Cancer Institute, National Institutes of Health, Bethesda, MD; HPV Immunology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD; Agencia Costarricense de Investigaciones Biomédicas (ACIB), formerly Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, San José, Costa Rica; Prevention and Implementation Group, International Agency for Research on Cancer, Lyon, France; DDL, Diagnostic Laboratory, Rijswijk, the Netherlands; Information Management Systems, Silver Spring, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djx158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075614PMC
February 2018

Cancer risk among lung transplant recipients with cystic fibrosis.

J Cyst Fibros 2017 01 15;16(1):91-97. Epub 2016 Aug 15.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcf.2016.07.011DOI Listing
January 2017

Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.

J Natl Cancer Inst 2016 Jan 14;108(1). Epub 2015 Oct 14.

Division of Cancer Epidemiology, and Genetics (DCB, ARK, MS, SW, MS, AH) and Center for Cancer Research (DRL, JTS), National Cancer Institute, NIH, Bethesda, MD; Proyecto Epidemiológico Guanacaste, Fundación INCIENSA, Costa Rica (RH, ACR, CP, SJ, PG); Early Detection and Prevention Section, International Agency for Research on Cancer, Lyon, France (RH); DDL Diagnostic Laboratory, Voorburg, the Netherlands (WQ, LS); Information Management Systems, Rockville, MD (JS).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/108/1/djv302.full.pdf
Web Search
http://jnci.oxfordjournals.org/lookup/doi/10.1093/jnci/djv30
Publisher Site
http://dx.doi.org/10.1093/jnci/djv302DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862406PMC
January 2016

A comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays.

Hum Vaccin Immunother 2015 ;11(2):337-46

a Human Papillomavirus (HPV) Immunology Laboratory; Leidos Biomedical Research, Inc. ; Frederick National Laboratory for Cancer Research ; Frederick , MD USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/21645515.2014.990851DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514413PMC
December 2015

The case for conducting a randomized clinical trial to assess the efficacy of a single dose of prophylactic HPV vaccines among adolescents.

J Natl Cancer Inst 2015 Mar 2;107(3). Epub 2015 Feb 2.

Division of Cancer Epidemiology and Genetics, Infections and Immunoepidemiology Branch (ARK, MS), Division of Cancer Prevention, Breast and Gynecologic Cancer Research Group (MES, VVS), Division of Cancer Epidemiology and Genetics, Human Genetics Program (MES), and Division of Cancer Epidemiology and Genetics, Hormonal and Reproductive Epidemiology Branch (VVS), National Cancer Institute, National Institutes of Health, Bethesda, MD; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN (VVS).

View Article

Download full-text PDF

Source
https://academic.oup.com/jnci/article-lookup/doi/10.1093/jnc
Publisher Site
http://dx.doi.org/10.1093/jnci/dju436DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326307PMC
March 2015

Logistic analysis of epidemiologic studies with augmentation sampling involving re-stratification and population expansion.

Biostatistics 2015 Jan 6;16(1):169-78. Epub 2014 Jun 6.

Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/biostatistics/kxu024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263221PMC
January 2015

Immunogenicity of bivalent HPV vaccine among partially vaccinated young adolescent girls in Uganda.

Vaccine 2014 Oct 16;32(47):6303-11. Epub 2014 Sep 16.

National Cancer Institute, Bethesda, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2014.08.071DOI Listing
October 2014

Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma.

Front Oncol 2014 19;4:119. Epub 2014 Jun 19.

Public Health Sciences Division, Fred Hutchinson Cancer Research Center , Seattle, WA , USA ; Department of Epidemiology, University of Washington , Seattle, WA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2014.00119DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062965PMC
July 2014

Number of human papillomavirus vaccine doses and condyloma.

JAMA 2014 Jun;311(23):2439

National Cancer Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2014.5009DOI Listing
June 2014

Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial.

Cancer Prev Res (Phila) 2013 Nov;6(11):1242-50

Division of Cancer Epidemiology and Genetics, Infections and Immunoepidemiology Branch, National Cancer Institute, 9609 Medical Center Drive, Rm 6-E224, MSC 9767, Bethesda, MD 20892.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-13-0203DOI Listing
November 2013

From Papanicolaou to papillomaviruses: evolving challenges in cervical cancer screening in the era of human papillomavirus vaccination.

J Natl Cancer Inst 2013 Oct 4;105(20):1524-6. Epub 2013 Oct 4.

Affiliation of authors: Division of Cancer Epidemiology and Genetics (MS), Division of Cancer Prevention (MES) and National Cancer Institute (MS, MES), Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797026PMC
October 2013

Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®).

Vaccine 2012 Dec 31;31(1):165-70. Epub 2012 Oct 31.

HPV Immunology Laboratory, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2012.10.067DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527627PMC
December 2012

Direct comparison of HPV16 serological assays used to define HPV-naïve women in HPV vaccine trials.

Cancer Epidemiol Biomarkers Prev 2012 Sep 2;21(9):1547-54. Epub 2012 Jul 2.

Division of Cancer Epidemiology and Genetics, Infections and Immunoepidemiology Branch, National Cancer Institute, NIH, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-12-0558DOI Listing
September 2012

Medical history and the risk of biliary tract cancers in Shanghai, China: implications for a role of inflammation.

Cancer Causes Control 2011 Sep 9;22(9):1289-96. Epub 2011 Jul 9.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, 6120 Executive Blvd., EPS 8011, MSC 7240, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-011-9802-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592608PMC
September 2011

Chronic typhoid infection and the risk of biliary tract cancer and stones in Shanghai, China.

Infect Agent Cancer 2011 May 2;6. Epub 2011 May 2.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1750-9378-6-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110129PMC
May 2011

Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.

Sex Transm Dis 2010 Nov;37(11):706-14

Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 6120 Executive Blvd, EPS, Room 7079, Rockville, MD 20852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/OLQ.0b013e3181e1a2c5DOI Listing
November 2010

Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.

J Natl Cancer Inst 2010 Nov 13;102(21):1653-62. Epub 2010 Oct 13.

Division of Cancer Epidemiology and Genetics, Infections and Immunoepidemiology Branch, National Cancer Institute, National Institutes of Health, 6120 Executive Blvd, Ste 550, Rockville, MD 20852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djq384DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970577PMC
November 2010

Determinants and correlation of systemic and cervical concentrations of total IgA and IgG.

Cancer Epidemiol Biomarkers Prev 2009 Oct;18(10):2672-6

Division of Cancer Epidemiology and Genetics, Infections and Immunoepidemiology Branch, National Cancer Institute, 6120 Executive Boulevard, Suite 550, Rockville, MD 20852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-09-0348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762345PMC
October 2009

Detection of precancerous cervical lesions is differential by human papillomavirus type.

Cancer Res 2009 Apr 7;69(8):3262-6. Epub 2009 Apr 7.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-08-4192DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155840PMC
April 2009

Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycle.

J Infect Dis 2009 Feb;199(3):455-63

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1086/596060DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158917PMC
February 2009

Cervical cancer prevention--cervical screening: science in evolution.

Obstet Gynecol Clin North Am 2007 Dec;34(4):739-60, ix

Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health/DHHS, 6120 Executive Blvd., Rockville, MD 20852, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S088985450700086
Publisher Site
http://dx.doi.org/10.1016/j.ogc.2007.09.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2762353PMC
December 2007

Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.

Obstet Gynecol 2007 Jun;109(6):1325-31

Division of Cancer Epidemiology and Genetics and Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.AOG.0000263461.71732.40DOI Listing
June 2007

Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica.

J Clin Microbiol 2007 May 7;45(5):1447-54. Epub 2007 Mar 7.

Division of Cancer Epidemiology and Genetics, Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, 6120 Executive Boulevard, Suite 550, Rockville, MD 20852, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JCM.02580-06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1865890PMC
May 2007

Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users.

AIDS Behav 2005 Sep;9(3):301-9

Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10461-005-9004-3DOI Listing
September 2005

Sexual risk behavior among injection drug users before widespread availability of highly active antiretroviral therapy.

AIDS Behav 2005 Sep;9(3):289-99

Department of Health Care and Epidemiology, University of British Columbia, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10461-005-9003-4DOI Listing
September 2005

Drug user treatment referrals and entry among participants of a needle exchange program.

Subst Use Misuse 2002 ;37(14):1869-86

University of California, Center for AIDS Prevention Studies, San Francisco, California, USA.

View Article

Download full-text PDF

Source
May 2003

Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998.

Am J Epidemiol 2002 Oct;156(7):641-53

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/aje/kwf086DOI Listing
October 2002

Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation.

Am J Epidemiol 2002 Jan;155(2):169-75

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/aje/155.2.169DOI Listing
January 2002